换一批
换一批Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.
作者：
Dimitrios,Makrakis [1]
;
Rafee,Talukder [1]
;
Genevieve Ihsiu,Lin [2]
;
Leonidas N,Diamantopoulos [3]
;
Scott,Dawsey [4]
;
Shilpa,Gupta [4]
;
Lucia,Carril-Ajuria [5]
;
Daniel,Castellano [5]
;
Ivan,de Kouchkovsky [6]
;
Vadim S,Koshkin [6]
;
Joseph J,Park [7]
;
Ajjai,Alva [7]
;
Mehmet A,Bilen [8]
;
Tyler F,Stewart [9]
;
Rana R,McKay [9]
;
Nishita,Tripathi [10]
;
Neeraj,Agarwal [10]
;
Naomi,Vather-Wu [11]
;
Yousef,Zakharia [12]
;
Rafael,Morales-Barrera [13]
;
Michael E,Devitt [14]
;
Alessio,Cortellini [15]
;
Claudia Angela Maria,Fulgenzi [15]
;
David J,Pinato [15]
;
Ariel,Nelson [16]
;
Christopher J,Hoimes [17]
;
Kavita,Gupta [18]
;
Benjamin A,Gartrell [18]
;
Alex,Sankin [18]
;
Abhishek,Tripathi [19]
;
Roubini,Zakopoulou [20]
;
Aristotelis,Bamias [21]
;
Jure,Murgic [22]
;
Ana,Fröbe [23]
;
Alejo,Rodriguez-Vida [24]
;
Alexandra,Drakaki [25]
;
Sandy,Liu [25]
;
Eric,Lu [25]
;
Vivek,Kumar [26]
;
Giuseppe Di,Lorenzo [27]
;
Monika,Joshi [28]
;
Pedro,Isaacsson-Velho [29]
;
Lucia Alonso,Buznego [30]
;
Ignacio,Duran [30]
;
Marcus,Moses [31]
;
Albert,Jang [31]
;
Pedro,Barata [31]
;
Guru,Sonpavde [32]
;
Evan Y,Yu [33]
;
Robert Bruce,Montgomery [33]
;
Petros,Grivas [34]
;
Ali Raza,Khaki [35]
作者单位：
Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA.
[1]
Department of Epidemiology, University of Washington, Seattle, WA.
[2]
Department of Medicine, University of Pittsburgh, Pittsburgh, PA.
[3]
Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.
[4]
Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.
[5]
Division of Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA.
[6]
Division of Oncology, Department of Medicine, University of Michigan, Ann Arbor, MI.
[7]
Winship Cancer Institute of Emory University, Atlanta, GA.
[8]
Division of Hematology/Oncology, Department of Medicine, University of California San Diego, La Jolla, CA.
[9]
Division of Oncology, Department of Medicine, University of Utah, Salt Lake City, UT.
[10]
Department of Medicine, University of Iowa, Iowa City, IA.
[11]
Division of Oncology, Department of Medicine, University of Iowa, Iowa City, IA.
[12]
Vall d'Hebron Institute of Oncology, Vall d' Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.
[13]
Division of Hematology/Oncology, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA.
[14]
Department of Surgery and Cancer, Imperial College London, London, UK.
[15]
Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
[16]
Division of Medical Oncology, Seidman Cancer Center at Case Comprehensive Cancer Center, Cleveland, OH; Division of Medical Oncology, Duke University, Durham, NC.
[17]
Departments of Medical Oncology and Urology, Montefiore Medical Center, Bronx, NY.
[18]
Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK.
[19]
Department of Clinical Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
[20]
2nd Propaedeutic Dept of Internal Medicine, ATTIKON University Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
[21]
Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Zagreb.
[22]
Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Zagreb; School of Dental Medicine, Zagreb, Croatia.
[23]
Medical Oncology Department, Hospital del Mar Research Institute, Barcelona, Spain.
[24]
Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA.
[25]
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
[26]
Oncology University of Molise and Medical Oncology ASL, Salerno, Italy.
[27]
Division of Hematology/Oncology, Department of Medicine, Penn State Cancer Institute, Hershey, PA.
[28]
Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Division of Oncology, Hospital Moinhos de Vento, Porto Alegre, Brazil.
[29]
Hospital Universitario Marques de Valdecilla. IDIVAL. Santander, Spain.
[30]
Deming Department of Medicine, Section of Hematology/Oncology, Tulane University, New Orleans, LA.
[31]
Genitourinary Oncology Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
[32]
Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
[33]
Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA. Electronic address: pgrivas@uw.edu.
[34]
Division of Oncology, Department of Medicine, Stanford University, Palo Alto, CA. Electronic address: alikhaki@stanford.edu.
[35]
主题词
癌, 移行细胞(Carcinoma, Transitional Cell);人类(Humans);肝肿瘤(Liver Neoplasms);回顾性研究(Retrospective Studies);膀胱肿瘤(Urinary Bladder Neoplasms)
DOI
10.1016/j.clgc.2022.06.001
PMID
35778337
发布时间
2024-09-23
- 浏览2
Clinical genitourinary cancer
Clinical genitourinary cancer
e440-e452页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
